Development of Bariatric and Metabolic Endoscopy

Overview

Journal Chin Med J (Engl)

Specialty General Medicine

Date 2017 Dec 23

PMID 29271386

Citations 2

Authors

Shi-Han Li

Yong-Jun Wang

Shu-Tian Zhang

Affiliations

Soon will be listed here.

Abstract

Objective: With the evolution of society and changes in human lifestyle, obesity is becoming increasingly prevalent worldwide, and obesity-related comorbidities such as diabetes, hyperlipidemia, hypertension, and coronary heart disease are more common. As a result, new devices and methods for bariatric and metabolic endoscopy are being developed for clinical use, offering new options for patients. This review discussed the progress in bariatric and metabolic endoscopy.

Data Sources: This review was based on data in articles published in the PubMed database up to September 2017, with the following keywords: "obesity", "endoscopy", "weight loss", and "metabolism".

Study Selection: Original articles about various endoscopic methods of weight loss and other reviews of bariatric and metabolic endoscopy were included and analyzed.

Results: The technology of bariatric and metabolic endoscopy has advanced rapidly in recent years. The intragastric balloon (IGB), with its comparatively long period of development, is the most mature and widely used instrument. Multiple new endoscopic devices have been created in recent years, with different targets to achieve weight loss. Despite the proliferation of new devices, the lack of clinical data results in a shortage of clinical experience and instruction in the use of this new equipment.

Conclusions: Bariatric and metabolic endoscopy would help obese people lose weight or prepare for bariatric surgery and hopefully alleviate some of the complications of bariatric procedures. Adequate studies and data are still needed for the new endoscopic devices.

Citing Articles

Management of diabesity: Current concepts.

Michaelidou M, Pappachan J, Jeeyavudeen M World J Diabetes. 2023; 14(4):396-411.

PMID: 37122433 PMC: 10130896. DOI: 10.4239/wjd.v14.i4.396.

Strategies in the Management of Adolescent Obesity.

Johnson V, Cao M, Czepiel K, Mushannen T, Nolen L, Stanford F Curr Pediatr Rep. 2020; 8(2):56-65.

PMID: 32632353 PMC: 7337011. DOI: 10.1007/s40124-020-00214-9.

References

Deviere J, Ojeda Valdes G, Cuevas Herrera L, Closset J, Le Moine O, Eisendrath P . Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study. Surg Endosc. 2007; 22(3):589-98. DOI: 10.1007/s00464-007-9662-5. View

Sandler B, Rumbaut R, Swain C, Torres G, Morales L, Gonzales L . Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve. Surg Endosc. 2011; 25(9):3028-33. DOI: 10.1007/s00464-011-1665-6. View

Abu Dayyeh B, Jirapinyo P, Weitzner Z, Barker C, Flicker M, Lautz D . Endoscopic sclerotherapy for the treatment of weight regain after Roux-en-Y gastric bypass: outcomes, complications, and predictors of response in 575 procedures. Gastrointest Endosc. 2012; 76(2):275-82. PMC: 4428559. DOI: 10.1016/j.gie.2012.03.1407. View

Abu Dayyeh B, Kumar N, Edmundowicz S, Jonnalagadda S, Larsen M, Sullivan S . ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015; 82(3):425-38.e5. DOI: 10.1016/j.gie.2015.03.1964. View

Horgan S, Jacobsen G, Weiss G, Oldham Jr J, Denk P, Borao F . Incisionless revision of post-Roux-en-Y bypass stomal and pouch dilation: multicenter registry results. Surg Obes Relat Dis. 2010; 6(3):290-5. DOI: 10.1016/j.soard.2009.12.011. View

Pajot G, Calderon G, Acosta A . Endoscopic Treatments for Obesity. Curr Treat Options Gastroenterol. 2017; 15(4):660-675. DOI: 10.1007/s11938-017-0158-7. View

Jirapinyo P, Abu Dayyeh B, Thompson C . Gastrojejunal anastomotic reduction for weight regain in roux-en-y gastric bypass patients: physiological, behavioral, and anatomical effects of endoscopic suturing and sclerotherapy. Surg Obes Relat Dis. 2016; 12(10):1810-1816. PMC: 5178872. DOI: 10.1016/j.soard.2016.09.036. View

Rothstein R . Bariatric and Metabolic Endoscopy. Gastrointest Endosc Clin N Am. 2017; 27(2):xv-xvi. DOI: 10.1016/j.giec.2017.01.006. View

Biertho L, Hould F, Lebel S, Biron S . Transoral endoscopic restrictive implant system: a new endoscopic technique for the treatment of obesity. Surg Obes Relat Dis. 2009; 6(2):203-5. DOI: 10.1016/j.soard.2009.08.006. View

10.

Lopez-Nava G, Sharaiha R, Vargas E, Bazerbachi F, Manoel G, Bautista-Castano I . Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up. Obes Surg. 2017; 27(10):2649-2655. DOI: 10.1007/s11695-017-2693-7. View

11.

Mathus-Vliegen E, Tytgat G . Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon. Gastroenterology. 1990; 99(2):362-9. DOI: 10.1016/0016-5085(90)91017-z. View

12.

Koehestanie P, de Jonge C, Berends F, Janssen I, Bouvy N, Greve J . The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann Surg. 2014; 260(6):984-92. DOI: 10.1097/SLA.0000000000000794. View

13.

Evans J, DeLegge M . Intragastric balloon therapy in the management of obesity: why the bad wrap?. JPEN J Parenter Enteral Nutr. 2011; 35(1):25-31. DOI: 10.1177/0148607110374476. View

14.

de Jong K, Mathus-Vliegen E, Veldhuyzen E, Eshuis J, Fockens P . Short-term safety and efficacy of the Trans-oral Endoscopic Restrictive Implant System for the treatment of obesity. Gastrointest Endosc. 2010; 72(3):497-504. DOI: 10.1016/j.gie.2010.02.053. View

15.

Lopez-Nava G, Galvao M, Bautista-Castano I, Fernandez-Corbelle J, Trell M . Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int Open. 2016; 4(2):E222-7. PMC: 4751018. DOI: 10.1055/s-0041-110771. View

16.

Jirapinyo P, Slattery J, Ryan M, Abu Dayyeh B, Lautz D, Thompson C . Evaluation of an endoscopic suturing device for transoral outlet reduction in patients with weight regain following Roux-en-Y gastric bypass. Endoscopy. 2013; 45(7):532-6. DOI: 10.1055/s-0032-1326638. View

17.

Garcia-Compean D, Mendoza-Fuerte E, Martinez J, Villarreal I, Maldonado H . Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study. Gastroenterol Clin Biol. 2005; 29(8-9):789-91. DOI: 10.1016/s0399-8320(05)86349-3. View

18.

Vlachou E, Direkz S, Murino A, Wylie P, Hamilton M, Murray C . Small bowel obstruction caused by a migrated Obalon gastric bariatric balloon: nonsurgical management by antegrade double-balloon panenteroscopy. Endoscopy. 2017; 48(S 01):E403-E404. DOI: 10.1055/s-0042-120289. View

19.

Fogel R, De Fogel J, Bonilla Y, De La Fuente R . Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc. 2008; 68(1):51-8. DOI: 10.1016/j.gie.2007.10.061. View

20.

Abd Ellatif M, Alfalah H, Asker W, El Nakeeb A, Magdy A, Thabet W . Place of upper endoscopy before and after bariatric surgery: A multicenter experience with 3219 patients. World J Gastrointest Endosc. 2016; 8(10):409-17. PMC: 4877533. DOI: 10.4253/wjge.v8.i10.409. View